查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1237856

自动化输血系统市场-增长、趋势和预测 (2023-2028)

Auto-Transfusion Systems Market - Growth, Trends, And Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，自动输血系统市场预计将以 5.2% 的复合年增长率增长。

由于外科手术的减少，COVID-19 在大流行期间对市场增长产生了重大影响。 这主要是由于世界各国政府实施的封锁限制导致非择期手术暂时中止或推迟。 大流行早期的这些情况影响了对自动输血系统的需求，从而影响了市场增长。 然而，放鬆管制后手术的恢復增加了对自动输血系统的需求，目前的市场情况预计将在预测期内推动市场增长。

市场增长的主要驱动力是由于慢性病和生活方式病的流行，外科手术的数量不断增加。 例如，根据 Moncloa Palace 于 2022 年 5 月发布的一份报告，2021 年西班牙将进行大约 4,781 例移植手术，比上一年的移植活动增加 8%。 此外，根据 NFHS 2021 年 11 月发布的统计数据，到 2021 年，城市地区剖腹产的比例将达到 3.2%，而农村地区的剖腹产比例将达到 17.6%。 如此大量的手术预计将推动对自动输血系统的需求并促进市场增长。 此外，自体输血系统的广泛使用也推动了市场的增长，因为献血和异体血液的稀缺对于净化患者的血液非常有用。 例如，美国红十字会在 2022 年 1 月发布的数据显示，自大流行开始以来，献血人数下降了 10%。

此外，市场参与者的努力，如合作伙伴关係、联合研究开发自动输血系统和提供安全有效的自动输血系统，也有望在预测期内促进市场增长。 例如，2022 年 5 月，Vetellus Specialties Ltd 与自动化输血设备製造商 Euroset s.r.l 签署了一份为期五年的合同。 该协议包括向 Eurosets 供应 Vertullus PC 技术涂层，用于心肺旁路装置等设备。 因此，上述因素，如手术次数多、献血和异体血液稀缺，以及产品批准率上升，预计将在预测期内推动市场增长。 然而，自动输血设备的高成本和与程序相关的风险预计将在预测期内抑制市场增长。

自动输血系统市场趋势

预计在预测期内，心臟外科领域将占据很大的市场份额

由于心脏病患病率的增加和心血管手术期间自体输血的提倡，预计心臟手术部分将在所研究的市场中占据很大份额。 例如，根据 BHF 2022 年 1 月的报告，截至 2021 年 11 月底，英国有近 284,000 人在等待时间敏感的心臟手术或其他心臟手术。 同样，BHF 2022 年 8 月的一份报告指出，英国有超过 760 万人患有心脏病和循环系统疾病。 因此，大量需要心臟手术的患者预计会增加对自动输血系统的需求，预计这将有助于预测期内的细分市场增长。

此外，根据 NCBI 在 2022 年 8 月发表的一篇文章，2021 年德国将有大约 29,947 例孤立的冠状动脉旁路移植术、36,714 例孤立的心臟瓣膜手术和 750 例辅助装置植入物被註册。 此外，根据国际组织和移植登记处（IRODAT）2022年公布的数据，2021年的心臟移植数量为中国738例，日本59例，澳大利亚116例。 大量此类心血管手术导致大量使用自动输血系统，这有助于市场的增长。 此外，捐赠血液和同种异体血液的日益稀缺也推动了这一领域的增长。 因此，由于上述因素，该部分在市场中占有很大份额，预计在预测期内将会增长。

自动输血系统市场-IMG1

预计在预测期内，北美将占据很大的市场份额。

在预测期内，预计北美将主导整个市场。 推动市场增长的因素包括主要参与者的存在、该地区的大量手术以及完善的医疗基础设施。 例如，根据 IRODAT 2022 年发布的数据，2021 年美国大约进行了 19,519 例肾臟移植、8,667 例肝臟移植和 3,863 例心臟移植。 同样，根据阿拉巴马大学 2021 年 11 月的一篇论文，美国每年进行近 350,000 例冠状动脉旁路移植术 (CABG) 手术。 因此，预计大量心血管手术将推动外科手术中对自动输血系统的需求，从而推动市场增长。

此外，加拿大有许多需要外科手术的慢性病，□□因此对自动输血系统的需求预计将推动加拿大的市场增长。 例如，根据加拿大政府2021年7月更新的数据，预计到2021年，整个加拿大将有630万年满65岁的加拿大人患有慢性病。 因此，加拿大老年人口的慢性病（主要需要手术干预）可能会导致对自动输血系统的高需求，从而推动市场增长。

此外，北美主要参与者的市场战略，如收购、合併和联盟，以提供先进有效的自动化输血系统，预计也将有助于该地区的市场增长。 例如，2021 年 10 月，Morgan Stanley Infrastructure 与 Specialty Care 合作并收购了 Specialty Care，以改善患者护理结果并发展公司。 Specialty Care 在美国提供自体输血系统服务。 因此，上述因素，如外科手术数量多和慢性病增加，预计将在预测期内促进该地区的市场增长。

自动输血系统市场-IMG2

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 手术次数增加
    • 献血短缺/同种异体血液短缺
  • 市场製约因素
    • 自体输血系统成本高
    • 与自体输血相关的风险
  • 波特的五力分析
    • 新进入者的威胁
    • 买家/消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争对手之间的竞争强度

第 5 章市场细分（按金额计算的市场规模 - 百万美元）

  • 按产品类型
    • 设备
    • 消耗品
  • 通过申请
    • 心臟外科
    • 骨科手术
    • 器官移植
    • 其他
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他
  • 地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Becton, Dickinson and Company
    • Beijing ZKSK Technology Co., Ltd.
    • Braile Biomedica
    • Zimmer Biomet
    • Medtronic Plc
    • LivaNova PLC
    • Redax Spa
    • Gen World Medical Devices
    • Haemonetics Corporation
    • Teleflex Incorporated
    • Fresenius Kabi
    • Soma Tech INTL

第七章市场机会与未来趋势

简介目录
Product Code: 68897

The auto-transfusion Systems market is projected to grow with a CAGR of 5.2% over the forecast period.

COVID-19 had a significant impact on the growth of the market during the pandemic period due to the reduction of surgical procedures. This was mainly due to the temporary suspension and postponement of non-elective surgeries due to the lockdown restriction by various governments across the world. These scenarios during the initial phase of the pandemic impacted the demand for auto-transfusion systems, thereby impacting the market's growth. However, the resumption of surgeries after the relaxation of regulations led to the growing demand for autotransfusion systems, and the current market scenario is expected to drive the growth of the market over the forecast period.

The major factor attributing to the growth of the market is the increase in the number of surgical procedures which can be attributed to the growing prevalence of chronic disease and lifestyle diseases. For instance, as per a report published by Moncloa Palace in May 2022, about 4,781 transplants were performed in Spain in 2021, an increase of 8% compared to transplant activity in the previous year. Moreover, as per the NFHS statistics released in November 2021, in India, 3.2% of births were delivered by cesarean section in urban areas, while 17.6% of births were delivered by cesarean section in rural areas till 2021. Such high surgical volume is expected to drive the demand for autotransfusion systems, thereby contributing to the growth of the market. Furthermore, the scarcity of donated blood or allogeneic blood is also boosting the market's growth owing to the extensive use of autotransfusion systems as they are highly useful in the purification of a patient's blood. For instance, according to the data published by the American Red Cross Society in January 2022, the red cross has experienced a 10% decline in the number of people donating blood since the beginning of the pandemic.

Additionally, the market player's initiatives such as partnerships, and collaborations to develop autotransfusion systems and provide safe and effective auto-transfusion systems are also expected to contribute to the growth of the market over the forecast period. For instance, in May 2022, Vetellus Specialities Ltd signed a five-year agreement with Euroset s.r.l, manufacturer of autotransfusion devices. The deal includes the supply of Vertullus PC technology coating to Eurosets for the application of equipment used in cardiopulmonary bypass surgery devices and others. Thus, the above-mentioned factors such as the high volume of surgeries, scarcity of donated blood or allogenic blood, and rising product approvals are expected to drive the growth of the market during the forecast period. However, the high cost of the auto-transfusion devices and the risk associated with the procedure are expected to restrain the market growth over the forecast period.

Auto-transfusion Systems Market Trends

Cardiac Surgeries Segment is Expected to Hold Significant Share in the Market Over the Forecast Period

The cardiac surgeries segment is expected to occupy a significant share of the studied market due to the increasing prevalence of cardiac diseases and recommendations for autologous transfusion during cardiovascular surgeries. For instance, according to BHF January 2022 report, nearly 284,000 people were waiting for time-critical heart operations and other heart procedures at the end of November 2021 in the United Kingdom. Similarly, the BHF report on August 2022 mentioned that over 7.6 million people in the United Kingdom are living with heart or circulatory disease. Hence, the high volume of patients in need of cardiac surgeries is expected to drive the demand for autotransfusion systems, thereby contributing to segment growth over the forecast period.

Furthermore, according to the article published by NCBI in August 2022, approximately 29,947 isolated coronary artery bypass grafting procedures, 36,714 isolated heart valve procedures, and 750 assist device implantations were registered in Germany in 2021. Additionally, the data published by International Registry in Organ Donation and Transplantation (IRODAT) in 2022 stated that the number of heart transplants in China was 738, 59 in Japan, and 116 in Australia in 2021. Such a high number of cardiovascular surgeries leads to the extensive usage of auto-transfusion systems, thereby contributing to the growth of the market. Furthermore, the growth of the segment is also increasing due to the growing inadequacy of donated blood or allogenic blood. Therefore, owing to the above-mentioned factors, the segment is expected to occupy a significant share of the market and grow over the forecast period.

Auto-Transfusion Systems Market - IMG1

North America is Expected to Hold Significant Share in the Market Over the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, a high number of surgeries in the region, and established healthcare infrastructure. For instance, as per the data published by IRODAT in 2022, in the United States, nearly 19,519 kidney transplants, 8,667 liver transplants, and 3,863 heart transplants were performed in 2021. Similarly, as per the article published by the University of Alabama in November 2021, nearly 350,000 Coronary Artery Bypass Graft (CABG) Surgeries are done each year in the United States. Hence, the high volume of cardiovascular procedures is expected to give rise to the demand for autotransfusion systems in surgical procedures, thereby boosting market growth.

Also, the demand for auto-transfusion systems due to the prevalence of chronic diseases among the Canadian population which may require surgical attention is expected to drive the growth of the market in Canada. For instance, as per data updated by the government of Canada in July 2021, overall, 6.3 million population of age 65 or more were estimated to be living with chronic conditions in 2021 in Canada. Thus, the chronic conditions among the elderly population in Canada mostly requiring surgical procedures are expected to result in high demand for autotransfusion systems, thereby propelling the market growth.

Moreover, the key player's market strategies such as acquisition, mergers, and collaborations in North America to provide advanced and effective autotransfusion systems are also expected to contribute to the growth of the market in this region. For instance, in October 2021, Morgan Stanley Infrastructure partnered and acquired Speciality Care Inc., to improve patient care outcomes and the company's growth. SpecialtyCare company provides autotransfusion system services in the United States. Thus, the above-mentioned factors such high volume of surgical procedures and the rise in chronic diseases are expected to contribute to the growth of the market over the forecast period in this region.

Auto-Transfusion Systems Market - IMG2

Auto-transfusion Systems Market Competitor Analysis

The Auto-transfusion Systems market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax, Teleflex Incorporated, Zimmer Biomet.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Surgical Procedures
    • 4.2.2 Scarcity of Donated Blood/Allogenic Blood
  • 4.3 Market Restraints
    • 4.3.1 High Costs Associated With Autotransfusion Systems
    • 4.3.2 Risks Associated With Autotransfusion
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Devices
    • 5.1.2 Consumables
  • 5.2 By Application
    • 5.2.1 Cardiac Surgeries
    • 5.2.2 Orthopedic Surgeries
    • 5.2.3 Organ Transplantation
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Beijing ZKSK Technology Co., Ltd.
    • 6.1.3 Braile Biomedica
    • 6.1.4 Zimmer Biomet
    • 6.1.5 Medtronic Plc
    • 6.1.6 LivaNova PLC
    • 6.1.7 Redax Spa
    • 6.1.8 Gen World Medical Devices
    • 6.1.9 Haemonetics Corporation
    • 6.1.10 Teleflex Incorporated
    • 6.1.11 Fresenius Kabi
    • 6.1.12 Soma Tech INTL

7 MARKET OPPORTUNITIES AND FUTURE TRENDS